title: First round to Amgen in EPO battle.
authors.forename: D
authors.initials: D
authors.lastname: Robertson
mesh_terms: D004921:Erythropoietin; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D013678:Technology, Pharmaceutical / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States
chemical_list: D004921:Erythropoietin